Literature DB >> 12631371

Studies on dialysate mixing in the Genius single-pass batch system for hemodialysis therapy.

Annemieke W Dhondt1, Raymond C Vanholder, Rita V De Smet, Stefaan A Claus, Marie-Anne Waterloos, Griet L Glorieux, Joris R Delanghe, Norbert H Lameire.   

Abstract

BACKGROUND: The Genius single-pass batch system for hemodialysis contains a closed reservoir and dialysate circuit of 75 L dialysate. The unused dialysate is withdrawn at the top of the reservoir and the spent fluid is reintroduced into the container at the bottom. Although it has been claimed that both fractions remain unmixed during the dialysis session, no direct proof of this assumption has yet been provided. In the present study, we investigated whether contamination of the unused dialysate with uremic solutes occurred and at which time point it began. Two different dialysate temperatures were compared.
METHODS: Ten chronic hemodialysis patients were dialyzed twice with the Genius system, with dialysate prepared at 37 degrees C and 38.5 degrees C, respectively. The sessions lasted 270 minutes with blood/dialysate flow set at 300 mL/min. Dialysate was sampled at 5, 60, 180, 210, 225, 230, 235, 240, 255, and 270 minutes both from the inlet and outlet dialysate line and blood was sampled from the arterial line predialysis, after 4 hours, and postdialysis. All samples were tested for osmolality, urea, creatinine, p-cresol, hippuric acid, and indoxyl sulfate.
RESULTS: Uremic solutes appeared in the inlet dialysate line between 3 hours 50 minutes and 4 hours 10 minutes after the start of dialysis, corresponding to 68.6 and 74.7 L spent dialysate, respectively (37 degrees C vs. 38.5 degrees C; P = NS). No difference in the amount of removed solutes and in the serum levels was observed between 37 degrees C and 38.5 degrees C. A Kt/V of 1.17 +/- 0.20 and 1.18 +/- 0.26, respectively, was reached with the 37 degrees C and 38.5 degrees C dialysate temperature (P = NS).
CONCLUSION: Contamination with uremic solutes occurred at the dialysate inlet only near the end of the session when small quantities of fresh dialysate were left in the container. Differences in dialysate temperature did not result in a different separation between used and unused dialysate, or in differences in removal of toxins or Kt/V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631371     DOI: 10.1046/j.1523-1755.2003.00862.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

Review 2.  [Renal replacement therapy in the intensive care unit].

Authors:  C Morath; N Miftari; R Dikow; C Hainer; M Zeier; V Schwenger; M A Weigand
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

3.  Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically-ill patients with acute kidney injury (AKI).

Authors:  Renato A Caires; Regina C R M Abdulkader; Verônica T Costa E Silva; Gillene S Ferreira; Emmanuel A Burdmann; Luis Yu; Etienne Macedo
Journal:  J Nephrol       Date:  2015-08-23       Impact factor: 3.902

4.  Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study.

Authors:  Vincenzo Panichi; Maria Teresa Rocchetti; Alessia Scatena; Alberto Rosati; Massimiliano Migliori; Francesco Pizzarelli; Loreto Gesualdo
Journal:  J Nephrol       Date:  2017-03-24       Impact factor: 3.902

5.  Pharmacokinetics of linezolid in septic patients with and without extended dialysis.

Authors:  Stefanie Swoboda; Michael C Ober; Christoph Lichtenstern; Soundos Saleh; Vedat Schwenger; Hans-Günther Sonntag; Walter Emil Haefeli; Georg Hempel; Torsten Hoppe-Tichy; Markus A Weigand
Journal:  Eur J Clin Pharmacol       Date:  2009-12-16       Impact factor: 2.953

6.  Elimination of fosfomycin during dialysis with the Genius system in septic patients.

Authors:  T Dimski; T Brandenburger; M Janczyk; T Slowinski; C MacKenzie; D Kindgen-Milles
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

7.  Protein-bound solute removal during extended multipass versus standard hemodialysis.

Authors:  Sunny Eloot; Wim Van Biesen; Mette Axelsen; Griet Glorieux; Robert Smith Pedersen; James Goya Heaf
Journal:  BMC Nephrol       Date:  2015-04-18       Impact factor: 2.388

8.  Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts.

Authors:  Vedat Schwenger; Markus A Weigand; Oskar Hoffmann; Ralf Dikow; Lars P Kihm; Jörg Seckinger; Nexhat Miftari; Matthias Schaier; Stefan Hofer; Caroline Haar; Peter P Nawroth; Martin Zeier; Eike Martin; Christian Morath
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

9.  Magnetic resonance-determined sodium removal from tissue stores in hemodialysis patients.

Authors:  Anke Dahlmann; Kathrin Dörfelt; Florian Eicher; Peter Linz; Christoph Kopp; Irina Mössinger; Stephan Horn; Beatrix Büschges-Seraphin; Peter Wabel; Matthias Hammon; Alexander Cavallaro; Kai-Uwe Eckardt; Peter Kotanko; Nathan W Levin; Bernd Johannes; Michael Uder; Friedrich C Luft; Dominik N Müller; Jens M Titze
Journal:  Kidney Int       Date:  2014-08-06       Impact factor: 10.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.